These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 32862262)

  • 21. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 23. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How does CKD affect HbA1c?
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
    Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
    Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of atherosclerosis on the relationship of glycemic control and mortality in diabetic patients on hemodialysis.
    Inaba M; Maekawa K; Okuno S; Imanishi Y; Hayashino Y; Emoto M; Shoji T; Ishimura E; Yamakawa T; Nishizawa Y
    Clin Nephrol; 2012 Oct; 78(4):273-80. PubMed ID: 22541674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA).
    Chujo K; Shima K; Tada H; Oohashi T; Minakuchi J; Kawashima S
    J Med Invest; 2006 Aug; 53(3-4):223-8. PubMed ID: 16953058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood glucose levels in peritoneal dialysis are better reflected by HbA1c than by glycated albumin.
    Watanabe Y; Ohno Y; Inoue T; Takane H; Okada H; Suzuki H
    Adv Perit Dial; 2014; 30():75-82. PubMed ID: 25338425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea.
    Shin KS; Park MS; Lee MY; Cho EH; Woo HY; Park H; Kwon MJ
    Scand J Clin Lab Invest; 2024 May; 84(3):168-173. PubMed ID: 38634263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of glycated albumin as another glycemic control marker.
    Koga M; Kasayama S
    Endocr J; 2010; 57(9):751-62. PubMed ID: 20724796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycated albumin: a potential biomarker in diabetes.
    Freitas PAC; Ehlert LR; Camargo JL
    Arch Endocrinol Metab; 2017; 61(3):296-304. PubMed ID: 28699985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan.
    Hsu P; Ai M; Kanda E; Yu NC; Chen HL; Chen HW; Cheng MH; Kohzuma T; Schaefer EJ; Yoshida M
    Atherosclerosis; 2015 Sep; 242(1):327-33. PubMed ID: 26247684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population.
    Raghav A; Ahmad J; Noor S; Alam K; Mishra BK
    Diabetes Metab Syndr; 2018 May; 12(3):381-385. PubMed ID: 29396252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
    Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
    J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
    Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
    J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of poor glycemic control and the monitoring utility of glycated albumin among diabetic patients attending clinic in tertiary hospitals in Dodoma, Tanzania: A cross-sectional study protocol.
    Mkumbi GG; Boaz M
    PLoS One; 2024; 19(9):e0289388. PubMed ID: 39231139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.